cis (2,3)-Dihydro tetrabenazine
CAS: 113627-25-1
Ref. 3D-FD21944
1mg | Ausgelaufen | ||
2mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen |
Produktinformation
- (2R,3S,11bS)-rel-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol(2a,3a,11b-a)-1,3,4,6,7,11b-He xahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol
Cis (2,3)-dihydro-tetrabenazine is a benzoquinoline that has been deuterated and is used as a drug for the treatment of Parkinson's disease. It is classified as an atypical antipsychotic agent and inhibits dopamine receptors in the brain. Cis (2,3)-dihydro-tetrabenazine has been shown to have a pharmacokinetic profile that is characterized by high bioavailability with low clearance rates. This drug has been shown to be an effective treatment for Parkinson's disease in vivo studies and regulatory experiments.